Multiple targets in coagulation, inflammation, and oxidative stress pathways

The term "Multiple targets in coagulation, inflammation, and oxidative stress pathways" refers to an integrated physiological network rather than a single molecular entity. These pathways are deeply interconnected in a process often called thromboinflammation, where the activation of the coagulation cascade (e.g., via thrombin and Factor Xa) triggers inflammatory signaling through protease-activated receptors (PARs) [PMID: 25730164]. Concurrently, the release of reactive oxygen species (ROS) during oxidative stress can further activate pro-coagulant factors and suppress natural anticoagulants like the protein C system [PMID: 32662052]. This triad of dysregulation is a hallmark of severe conditions such as sepsis, acute respiratory distress syndrome (ARDS), and cardiovascular disease [PMID: 24259440]. Drugs targeting this broad network, such as activated protein C (Drotrecogin alfa) or pleiotropic antioxidants like melatonin, aim to interrupt the self-reinforcing cycle of tissue damage by modulating several receptors and enzymes simultaneously [PMID: 11233966]. Because these pathways involve fundamental host defense mechanisms, therapeutic intervention requires a delicate balance between efficacy and the risk of systemic adverse effects like hemorrhage.

Other names

Thrombo-inflammatory pathwaysCoagulation-inflammation-redox networkCross-talk pathways of hemostasis and inflammation

Simultaneous modulation of multiple proteins including coagulation factors (Factor Va/VIIIa), protease-activated receptors (PAR-1), and redox-sensitive transcription factors (NF-kappaB, Nrf2) to restore systemic homeostasis.